Addiction is a disease of the brain and it is undertreated. Medication for Opioid Use Disorder (MOUD) is gaining support and momentum at the national and state levels as a critical tool in the fight against opioid use disorder. MOUD involves the use of specific prescription medications to ease withdrawal symptoms and reduce psychological cravings in patients with opioid use disorder. When combined with counseling and other behavioral health services, MOUD has been shown to reduce illicit drug use and overdose deaths.
As of Dec. 29, 2022, no waiver of any sort is needed to prescribe buprenorphine for opioid use disorder, and there are no limits on the number of patients that can be treated. Clinicians who prescribe buprenorphine are expected to provide care that meets accepted and prevailing standards for the treatment of opioid use disorder. PAs who prescribe buprenorphine should ensure that their supervising physician holds a valid DEA registration and is familiar with prescribing buprenorphine for opioid use disorder.
The resources on this page can help you learn more about getting started.
Note: if you are looking for controlled substance CME classes, click here.
